The India continuous glucose monitoring devices market size was estimated at USD 45.92 million in 2025 and is expected to reach USD 105.67 million in 2033, growing at a CAGR of 11.56% from 2026 to 2033. A shift toward proactive diabetes management and the adoption of digital health tools are fueling demand.
The rising geriatric population and sedentary lifestyles contribute to the disease burden, necessitating the development of advanced monitoring solutions. Furthermore, expanding healthcare infrastructure, the availability of CGM devices through e-commerce and pharmacies, and collaborations between global players and Indian healthcare providers enhance accessibility. Technological advancements like sensor accuracy, app integration, and data sharing further support market growth across urban and semi-urban areas.
India, a key country in the International Diabetes Federation (IDF) South-East Asia region, is grappling with a growing diabetes crisis. Of the 589 million global cases of diabetes, 107 million are in this region. By 2050, the regional number is expected to rise to 185 million. India alone has a staggering 89.8 million adult diabetes cases, with a 10.5% adult prevalence rate among its 947 million adult population.
To raise awareness and promote better care, World Diabetes Day is observed every year on November 14. The 2024 theme, “Breaking Barriers, Bridging Gaps,” emphasizes collaborative action to improve diagnosis, treatment, and equal access to care. It also encourages health systems to address care disparities and foster inclusion.
Diabetes is a chronic disease caused by insufficient insulin production or improper insulin usage, leading to high blood glucose levels. Left uncontrolled, it can damage vital organs and cause severe complications, including heart disease, kidney failure, blindness, and nerve damage. Early symptoms include frequent urination, thirst, fatigue, blurred vision, and unexplained weight loss.
This product will be delivered within 1-3 business days.
The rising geriatric population and sedentary lifestyles contribute to the disease burden, necessitating the development of advanced monitoring solutions. Furthermore, expanding healthcare infrastructure, the availability of CGM devices through e-commerce and pharmacies, and collaborations between global players and Indian healthcare providers enhance accessibility. Technological advancements like sensor accuracy, app integration, and data sharing further support market growth across urban and semi-urban areas.
India, a key country in the International Diabetes Federation (IDF) South-East Asia region, is grappling with a growing diabetes crisis. Of the 589 million global cases of diabetes, 107 million are in this region. By 2050, the regional number is expected to rise to 185 million. India alone has a staggering 89.8 million adult diabetes cases, with a 10.5% adult prevalence rate among its 947 million adult population.
To raise awareness and promote better care, World Diabetes Day is observed every year on November 14. The 2024 theme, “Breaking Barriers, Bridging Gaps,” emphasizes collaborative action to improve diagnosis, treatment, and equal access to care. It also encourages health systems to address care disparities and foster inclusion.
Diabetes is a chronic disease caused by insufficient insulin production or improper insulin usage, leading to high blood glucose levels. Left uncontrolled, it can damage vital organs and cause severe complications, including heart disease, kidney failure, blindness, and nerve damage. Early symptoms include frequent urination, thirst, fatigue, blurred vision, and unexplained weight loss.
India Continuous Glucose Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at the country level and analyzes the latest industry trends across sub-segments from 2021 to 2033. For this study, the analyst has segmented the India continuous glucose monitoring (CGM) devices market report based on product, connectivity, indication, and distribution channel:Product Outlook (Revenue, USD Million, 2021-2033)
- Sensors
- Transmitters
- Device/Readers
- Applicators
Connectivity Outlook (Revenue, USD Million, 2021-2033)
- Bluetooth
- 4G/Cellular
- NFC (Near Field Communication)
Indication Outlook (Revenue, USD Million, 2021-2033)
- Type 1 Diabetes
- Type 2 Diabetes
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Pharmacies
- E-commerce
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. India CGM Devices Market Variables, Trends, & Scope
Chapter 4. India CGM Devices Market: Product Estimates & Trend Analysis
Chapter 5. India CGM Devices Market: Connectivity Estimates & Trend Analysis
Chapter 6. India CGM Devices Market: Indication Estimates & Trend Analysis
Chapter 7. India CGM Devices Market: Distribution Channel Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Sugar Fit
- Health Arx Technologies Pvt. Ltd.
- Healthify CGM
- DrStore Healthcare Services India Pvt Ltd
- GoodFlip
- Actofit
- AmiciCare
